Puff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDA

Aurora Cannabis (TSX:ACB) earned record annual revenue and adjusted EBITDA in fiscal 2026, substantiating its shift into the medical market.

Apotex Health completes largest life sciences IPO in TSX history

Apotex Health (TSX:APTX) began trading today on the TSX, marking the largest life sciences IPO by total proceeds in the exchange's history.

Remote healthcare disruptor tops one million patient visits

Remote healthcare company UniDoc Health (CSE:UDOC) surpasses one million patient visits through its enterprise eHealth platform.

Healthcare micro-cap climbs after million-prescription milestone

TelyRx (TSX:TELY) recently filled its one millionth prescription, furthering its mission of expanding access to medications across the US.

MindBio unveils AI-powered fatigue detection breakthrough using voice analytics

MindBio (CSE:MBIO) developed proprietary AI that analyzes speech to detect fatigue and impairment from active substances in real time.

The mental health economy: Investing in the world’s fastest-growing invisible market

Mental health is shifting from a neglected issue to a major economic sector, driven by rising demand, workplace spending, and digital access.The mental health…

2 small-cap stocks built for the long haul

Running a fine-tooth comb through SBC Medical Group and Delta Gold Technologies, two small-cap stocks with solid long-term potential.

Meet the micro-cap biotech company reinventing regenerative medicine

An in-depth analysis of NurExone Biologic, a pre-clinical company ushering regenerative medicine into its next era of growth.

Buzz on the Bullboards: Where quarterly reports meet business outlooks

Canadian equities have experienced a volatile stretch over the past week, with both the TSX Composite...

BriaCell receives FDA green light to advance breast cancer immunotherapy

BriaCell Therapeutics (NASDAQ:BCTX) got FDA approval for clinical trials of a new off-the-shelf immunotherapy for metastatic breast cancer.

Cannabix delivers marijuana breath test to Eastern Canada workplace testing clinic

Cannabix Technologies (CSE:BLO) delivered its Marijuana Breath Test devices to a workplace drug and alcohol testing clinic in eastern Canada.

Biotech company patenting world’s first AI voice test for substance abuse

Biotech company MindBio files a patent application for the world's first AI model to detect substance abuse though vocal analysis.

2 biotech stocks bridging the gap between unmet need and next-gen medicine

Exploring Lunai Bioworks and TheraCryf, two biotech stocks taking early strides towards improving the lives of tens of millions of patients.

Marvel Biosciences advancing autism drug for children

Marvel Biosciences announces two pediatric-friendly versions of its drug candidate, MB-204, which may help to treat autism and depression.

Voice is becoming the new frontier in safety AI

MindBio Therapeutics (CSE:MBIO) is a biotechnology and applied AI company commercializing proprietary voice analytics technology.

Buzz on the Bullboards: Return trajectories vs emerging threats

Global markets entered this week uneasy, as geopolitics once again took centre stage. Traders brace for volatility tied to Middle East.

MindBio completes development of platform for voice‑based intoxication detection

MindBio (CSE:MBIO) launched Intox Collect, expanding and accelerating voice based data collection for detecting drug and alcohol impairment.